Dihydroquercetin is not mutagenic and less toxic than the related compound quercetin. It acts as a potentialchemopreventive agent by regulating genes via an ARE-dependent mechanism. Taxifolin has shown to inhibit theovarian cancer cell growth in a dose-dependent manner. There is also a strong correlation (with a correlation coefficient of 0.93) between the antiproliferative effects of dihydroquercetin (DHQ, Dihydroquercetin) derivatives on murine skin fibroblasts and human breast cancer cells.

1. strong antioxidant capacity
2. enhance immunity
3. prevention and treatment of cancer cancer
4. prevention and treatment of cardiovascular and cerebrovascular diseases
5. balance blood lipid
6. detoxification and protection of liver
7. improve the function of stomach and intestines
8. whitening skin.